Johnson & Johnson (JNJ) Presents at Raymond James 42nd Annual Institutional Investors Conference Call TranscriptSeeking Alpha • 03/03/21
Johnson & Johnson CEO on Merck vaccine partnership: 'Extraordinary times take extraordinary efforts'CNBC • 03/03/21
J&J ETFs to Shine Bright as FDA Grants EUA for Coronavirus VaccineZacks Investment Research • 03/02/21
Merck, J&J Reportedly Forge Covid Vaccine Alliance — Here's What You Need To KnowInvestors Business Daily • 03/02/21
White House using Defense Production Act to equip Merck plants for Johnson & Johnson vaccineReuters • 03/02/21
Merck will reportedly help produce Johnson & Johnson COVID-19 vaccine shots after failing to make its own (MRK, JNJ)Business Insider • 03/02/21
Coronavirus Update: U.S. COVID vaccine supply to be boosted by Merck helping make J&J vaccineMarket Watch • 03/02/21
Merck To Offer Hand With JNJ COVID-19 Vaccine Production, Biden Administration Says: ReportBenzinga • 03/02/21
Biden reportedly set to announce Merck assistance in J&J vaccine manufacturingMarket Watch • 03/02/21
CDC says J&J Covid vaccine is OK for people who have allergic reaction to Pfizer or Moderna'sCNBC • 03/01/21
Johnson & Johnson waiting on new plant approval to ship high volumes of vaccine: executiveReuters • 03/01/21
Johnson & Johnson's vaccine is approved — here's why experts say you should take what you can getCNBC • 03/01/21
Vaccine Acceptance Rises As Americans Eye Covid Mutations: IBD/TIPP PollInvestors Business Daily • 03/01/21